Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e65659a94131d0ad6c29212eef191d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6d975a12f1335a10d21203946ebbdd8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
filingDate |
2006-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17faf02f25fe50f86496347ec69d1ce1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e3f2dde2221bad908cacc6034488dc |
publicationDate |
2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006078598-A2 |
titleOfInvention |
Mitotic kinesin inhibitors |
abstract |
The present invention relates to fluorinated 2-aminomethylquinazolinone derivatives that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009061595-A1 |
priorityDate |
2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |